• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    United Therapeutics Corporation - Common Stock (NQ:UTHR)

    479.11 +4.97 (+1.05%)
    Streaming Delayed Price Updated: 11:26 AM EST, Dec 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 73,711
    Open 474.14
    Bid (Size) 477.91 (160)
    Ask (Size) 479.67 (40)
    Prev. Close 474.14
    Today's Range 470.13 - 479.37
    52wk Range 266.98 - 492.62
    Shares Outstanding 44,891,523
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    United Therapeutics Corp (NASDAQ:UTHR): A Caviar Cruise Quality Investment ↗
    United Therapeutics (UTHR) excels as a Caviar Cruise quality stock with strong growth, high profitability, a debt-free balance sheet, and exceptional returns on capital. 
    Via Chartmill
    News headline image
    2 Mooning Stocks on Our Buy List and 1 That Underwhelm
    The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
    Via StockStory

    Performance

    YTD
    +33.0%
    +33.0%
    1 Month
    +9.2%
    +9.2%
    3 Month
    +18.4%
    +18.4%
    6 Month
    +47.8%
    +47.8%
    1 Year
    +29.4%
    +29.4%

    More News

    Read More
    News headline image
    Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today ↗
    Via Benzinga
    News headline image
    United Therapeutics Corp (NASDAQ:UTHR) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    3 Reasons Investors Love United Therapeutics (UTHR)
    Via StockStory
    News headline image
    Earnings Scheduled For October 29, 2025 ↗
    Via Benzinga
    News headline image
    Is United Therapeutics Corp Gaining or Losing Market Support? ↗
    Via Benzinga
    News headline image
    P/E Ratio Insights for United Therapeutics ↗
    Via Benzinga
    News headline image
    My Top Vanguard Index ETF Pick for 2026 ↗
    Via The Motley Fool
    Topics ETFs Economy Stocks
    News headline image
    The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call
    Via StockStory
    Topics Earnings Intellectual Property
    News headline image
    If You Invested $100 In United Therapeutics Stock 5 Years Ago, You Would Have This Much Today ↗
    Via Benzinga
    News headline image
    United Therapeutics Corporation to Present at Upcoming Investor Conferences
    From United Therapeutics Corporation
    Via Business Wire
    News headline image
    United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
    From United Therapeutics Corporation
    Via Business Wire
    News headline image
    2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid
    Via StockStory
    News headline image
    United Therapeutics Corp (NASDAQ:UTHR) Offers Affordable Growth with Strong Profitability ↗
    Via Chartmill
    News headline image
    United Therapeutics (UTHR) Earnings Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property
    News headline image
    Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports ↗
    Via Investor's Business Daily
    News headline image
    UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook
    Via StockStory
    News headline image
    Why Is United Therapeutics (UTHR) Stock Soaring Today
    Via StockStory
    News headline image
    Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday ↗
    Via Benzinga
    News headline image
    United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short ↗
    Via Investor's Business Daily
    News headline image
    United Therapeutics Corp (NASDAQ:UTHR) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates ↗
    Via Chartmill
    News headline image
    S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday? ↗
    Via Benzinga
    Topics Economy Stocks
    News headline image
    United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings
    Via StockStory
    News headline image
    United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
    From United Therapeutics Corporation
    Via Business Wire

    Frequently Asked Questions

    Is United Therapeutics Corporation - Common Stock publicly traded?
    Yes, United Therapeutics Corporation - Common Stock is publicly traded.
    What exchange does United Therapeutics Corporation - Common Stock trade on?
    United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for United Therapeutics Corporation - Common Stock?
    The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
    What is the current price of United Therapeutics Corporation - Common Stock?
    The current price of United Therapeutics Corporation - Common Stock is 479.11
    When was United Therapeutics Corporation - Common Stock last traded?
    The last trade of United Therapeutics Corporation - Common Stock was at 12/03/25 11:26 AM ET
    What is the market capitalization of United Therapeutics Corporation - Common Stock?
    The market capitalization of United Therapeutics Corporation - Common Stock is 21.51B
    How many shares of United Therapeutics Corporation - Common Stock are outstanding?
    United Therapeutics Corporation - Common Stock has 22B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.